FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994170015> ?p ?o ?g. }

• W1994170015 abstract "Human glioblastoma is the most frequent and aggressive form of brain tumour in the adult population. Proteolytic turnover of tumour suppressors by the ubiquitin–proteasome system is a mechanism that tumour cells can adopt to sustain their growth and invasiveness. However, the identity of ubiquitin–proteasome targets and regulators in glioblastoma are still unknown. Here we report that the RING ligase praja2 ubiquitylates and degrades Mob, a core component of NDR/LATS kinase and a positive regulator of the tumour-suppressor Hippo cascade. Degradation of Mob through the ubiquitin–proteasome system attenuates the Hippo cascade and sustains glioblastoma growth in vivo. Accordingly, accumulation of praja2 during the transition from low- to high-grade glioma is associated with significant downregulation of the Hippo pathway. These findings identify praja2 as a novel upstream regulator of the Hippo cascade, linking the ubiquitin proteasome system to deregulated glioblastoma growth. Tumour suppressors can be inactivated in cancer not only as a result of mutation, but also by proteolytic degradation. Here the authors show that, during glioma development, the accumulation of the ubiquitin ligase praja2 sustains tumour growth by degrading MOB1—a core component of the Hippo pathway." @default.
• W1994170015 created "2016-06-24" @default.
• W1994170015 creator A5011875652 @default.
• W1994170015 creator A5019925732 @default.
• W1994170015 creator A5021706700 @default.
• W1994170015 creator A5023504895 @default.
• W1994170015 creator A5023653701 @default.
• W1994170015 creator A5024427677 @default.
• W1994170015 creator A5030867430 @default.
• W1994170015 creator A5037259751 @default.
• W1994170015 creator A5037870772 @default.
• W1994170015 creator A5042509214 @default.
• W1994170015 creator A5048754395 @default.
• W1994170015 creator A5051287878 @default.
• W1994170015 creator A5052734225 @default.
• W1994170015 creator A5063688819 @default.
• W1994170015 creator A5067350223 @default.
• W1994170015 creator A5072100926 @default.
• W1994170015 creator A5077230365 @default.
• W1994170015 creator A5091666559 @default.
• W1994170015 date "2013-05-07" @default.
• W1994170015 modified "2023-10-18" @default.
• W1994170015 title "Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth" @default.
• W1994170015 cites W1267435173 @default.
• W1994170015 cites W1518598504 @default.
• W1994170015 cites W1950498857 @default.
• W1994170015 cites W1974673111 @default.
• W1994170015 cites W1977266192 @default.
• W1994170015 cites W1978655858 @default.
• W1994170015 cites W1981011148 @default.
• W1994170015 cites W1992859930 @default.
• W1994170015 cites W1995926251 @default.
• W1994170015 cites W1997915675 @default.
• W1994170015 cites W2011892634 @default.
• W1994170015 cites W2016054516 @default.
• W1994170015 cites W2016672123 @default.
• W1994170015 cites W2020131167 @default.
• W1994170015 cites W2024377156 @default.
• W1994170015 cites W2029935275 @default.
• W1994170015 cites W2033360354 @default.
• W1994170015 cites W2033696318 @default.
• W1994170015 cites W2035799305 @default.
• W1994170015 cites W2039075677 @default.
• W1994170015 cites W2050730054 @default.
• W1994170015 cites W2055525759 @default.
• W1994170015 cites W2055953592 @default.
• W1994170015 cites W2058374433 @default.
• W1994170015 cites W2060551076 @default.
• W1994170015 cites W2069415914 @default.
• W1994170015 cites W2073568903 @default.
• W1994170015 cites W2079828953 @default.
• W1994170015 cites W2082979850 @default.
• W1994170015 cites W2084372424 @default.
• W1994170015 cites W2085197940 @default.
• W1994170015 cites W2090840153 @default.
• W1994170015 cites W2102267300 @default.
• W1994170015 cites W2105315565 @default.
• W1994170015 cites W2105481533 @default.
• W1994170015 cites W2106217467 @default.
• W1994170015 cites W2109838283 @default.
• W1994170015 cites W2113588085 @default.
• W1994170015 cites W2122545341 @default.
• W1994170015 cites W2123159500 @default.
• W1994170015 cites W2126817554 @default.
• W1994170015 cites W2134937820 @default.
• W1994170015 cites W2148751141 @default.
• W1994170015 cites W2153558039 @default.
• W1994170015 cites W2153946010 @default.
• W1994170015 cites W2164049072 @default.
• W1994170015 cites W2171634952 @default.
• W1994170015 cites W3187128191 @default.
• W1994170015 cites W4211107382 @default.
• W1994170015 cites W4376596128 @default.
• W1994170015 doi "https://doi.org/10.1038/ncomms2791" @default.
• W1994170015 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3674242" @default.
• W1994170015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23652010" @default.
• W1994170015 hasPublicationYear "2013" @default.
• W1994170015 type Work @default.
• W1994170015 sameAs 1994170015 @default.
• W1994170015 citedByCount "92" @default.
• W1994170015 countsByYear W19941700152013 @default.
• W1994170015 countsByYear W19941700152014 @default.
• W1994170015 countsByYear W19941700152015 @default.
• W1994170015 countsByYear W19941700152016 @default.
• W1994170015 countsByYear W19941700152017 @default.
• W1994170015 countsByYear W19941700152018 @default.
• W1994170015 countsByYear W19941700152019 @default.
• W1994170015 countsByYear W19941700152020 @default.
• W1994170015 countsByYear W19941700152021 @default.
• W1994170015 countsByYear W19941700152022 @default.
• W1994170015 countsByYear W19941700152023 @default.
• W1994170015 crossrefType "journal-article" @default.
• W1994170015 hasAuthorship W1994170015A5011875652 @default.
• W1994170015 hasAuthorship W1994170015A5019925732 @default.
• W1994170015 hasAuthorship W1994170015A5021706700 @default.
• W1994170015 hasAuthorship W1994170015A5023504895 @default.
• W1994170015 hasAuthorship W1994170015A5023653701 @default.
• W1994170015 hasAuthorship W1994170015A5024427677 @default.
• W1994170015 hasAuthorship W1994170015A5030867430 @default.
• W1994170015 hasAuthorship W1994170015A5037259751 @default.

• next